Medicare could save millions of dollars every year by changing the way they package Alzheimer's medication.

SGLT-2 inhibitors were associated with the lowest risk for incidental dementia relative to DPP-4 inhibitors and GLP-1RAs in type 2 diabetes.

A new study from Columbia University shows that combining a brief smell test with a short memory exam can predict cognitive ...

Medicare could save up to 74% of the money lost from discarded Alzheimer's drug lecanemab by the simple introduction of a new vial size that would reduce the amount of unused medication that is thrown ...

Not only that, research has shown that music might help regenerate the brain and its connections. Many causes of dementia ...

Sociologist Elena Portacolone was taken aback. Many of the older adults in San Francisco she visited at home for a research ...

Researchers from Lancaster University and international collaborators have taken a significant step forward in developing a ...

If you are one of the millions with heart disease, you have a higher risk for future dementia, according to the American ...

An Alzheimer’s treatment from idea to market can take up to 20 years. After a long hiatus, the U.S. Food and Drug Administration (FDA) has approved three new drugs to treat Alzheimer’s since June 2021 ...

Researchers have found that the drug dronabinol — a synthetic version of the psychoactive THC compound in cannabis — helped ...

Dementia is a devastating disease that impacts one in 10 older Americans. But while many people want to avoid developing ...

More than a dozen long-term care technology programs were honored as Gold medalists at the 14th Annual McKnight’s Tech Awards ...